KaloCyte
Pre-clinicalKaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.
Founded
2017
Focus
Biologics
About
KaloCyte is developing ErythroMer™, a dried, bio-inspired artificial red blood cell, to treat life-threatening blood loss when stored red blood cells are unavailable, undesirable or in short supply.
Funding History
2Total raised: $3.5M
Seed$3MUndisclosedAug 15, 2022
Grant$500KNIHJun 15, 2021
Company Info
TypePrivate
Founded2017
LocationSt. Louis, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile